Project Description

Europe faces a diabetes epidemic. More than 55 million people in Europe are currently diagnosed with diabetes and as this number is predicted to keep rising in future years, the disease is certain to stay one of the most challenging health problems this century.

Despite the high prevalence of diabetes, the choice of anti-diabetic drugs is still limited and many patients with diabetes do not achieve good glycaemic control.

The key technology for identifying promising future pharmaceutical anti-diabetic compounds already in early phases of development is the euglycaemic glucose clamp technique. This method measures the effectiveness of a new anti-diabetic drug to lower blood glucose levels by stabilising a subject’s blood glucose concentration at a target level through a variable infusion of glucose.

The EU-CLAMP Project aims to facilitate clinical research with new anti-diabetic compounds by developing a new generation automated clamp device.

General Information

The EU-CLAMP project receives funding from the European Union’s Seventh Framework Programme under the ‘Research for SMEs’ scheme (FP7-SME-2010-1).